144 related articles for article (PubMed ID: 30530749)
21. Ibrutinib significantly inhibited Bruton's tyrosine kinase (BTK) phosphorylation,
Chu Y; Lee S; Shah T; Yin C; Barth M; Miles RR; Ayello J; Morris E; Harrison L; Van de Ven C; Galardy P; Goldman SC; Lim MS; Hermiston M; McAllister-Lucas LM; Giulino-Roth L; Perkins SL; Cairo MS
Oncoimmunology; 2019; 8(1):e1512455. PubMed ID: 30546948
[TBL] [Abstract][Full Text] [Related]
22. MYD88 L265P mutations identify a prognostic gene expression signature and a pathway for targeted inhibition in CLL.
Improgo MR; Tesar B; Klitgaard JL; Magori-Cohen R; Yu L; Kasar S; Chaudhary D; Miao W; Fernandes SM; Hoang K; Westlin WF; Kim HT; Brown JR
Br J Haematol; 2019 Mar; 184(6):925-936. PubMed ID: 30537114
[TBL] [Abstract][Full Text] [Related]
23. The NOTCH Pathway and Its Mutations in Mature B Cell Malignancies.
Arruga F; Vaisitti T; Deaglio S
Front Oncol; 2018; 8():550. PubMed ID: 30534535
[TBL] [Abstract][Full Text] [Related]
24.
Xiao W; Bharadwaj M; Levine M; Farnhoud N; Pastore F; Getta BM; Hultquist A; Famulare C; Medina JS; Patel MA; Gao Q; Lewis N; Pichardo J; Baik J; Shaffer B; Giralt S; Rampal R; Devlin S; Cimera R; Zhang Y; E Arcila M; Papaemmanuil E; Levine RL; Roshal M
Blood Adv; 2018 Dec; 2(23):3526-3539. PubMed ID: 30530780
[TBL] [Abstract][Full Text] [Related]
25. ATM and TP53 mutations show mutual exclusivity but distinct clinical impact in mantle cell lymphoma patients.
Mareckova A; Malcikova J; Tom N; Pal K; Radova L; Salek D; Janikova A; Moulis M; Smardova J; Kren L; Mayer J; Trbusek M
Leuk Lymphoma; 2019 Jun; 60(6):1420-1428. PubMed ID: 30626249
[TBL] [Abstract][Full Text] [Related]
26. Association of early disease progression and very poor survival in the GALLIUM study in follicular lymphoma: benefit of obinutuzumab in reducing the rate of early progression.
Seymour JF; Marcus R; Davies A; Gallop-Evans E; Grigg A; Haynes A; Herold M; Illmer T; Nilsson-Ehle H; Sökler M; Dünzinger U; Nielsen T; Launonen A; Hiddemann W
Haematologica; 2019 Jun; 104(6):1202-1208. PubMed ID: 30573503
[TBL] [Abstract][Full Text] [Related]
27. Metabolic Reprogramming of Non-Hodgkin's B-Cell Lymphomas and Potential Therapeutic Strategies.
Ricci JE; Chiche J
Front Oncol; 2018; 8():556. PubMed ID: 30564554
[TBL] [Abstract][Full Text] [Related]
28. SOX11 promotes osteoarthritis through induction of TNF-α.
Xu S; Yu J; Wang Z; Ni C; Xia L; Tang T
Pathol Res Pract; 2019 Jul; 215(7):152442. PubMed ID: 31078342
[TBL] [Abstract][Full Text] [Related]
29. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes.
Nadeu F; Martin-Garcia D; Clot G; Díaz-Navarro A; Duran-Ferrer M; Navarro A; Vilarrasa-Blasi R; Kulis M; Royo R; Gutiérrez-Abril J; Valdés-Mas R; López C; Chapaprieta V; Puiggros M; Castellano G; Costa D; Aymerich M; Jares P; Espinet B; Muntañola A; Ribera-Cortada I; Siebert R; Colomer D; Torrents D; Gine E; López-Guillermo A; Küppers R; Martin-Subero JI; Puente XS; Beà S; Campo E
Blood; 2020 Sep; 136(12):1419-1432. PubMed ID: 32584970
[TBL] [Abstract][Full Text] [Related]
30. Mantle cell lymphoma: 2019 update on the diagnosis, pathogenesis, prognostication, and management.
Jain P; Wang M
Am J Hematol; 2019 Jun; 94(6):710-725. PubMed ID: 30963600
[TBL] [Abstract][Full Text] [Related]
31. Genetic mutations and features of mantle cell lymphoma: a systematic review and meta-analysis.
Hill HA; Qi X; Jain P; Nomie K; Wang Y; Zhou S; Wang ML
Blood Adv; 2020 Jul; 4(13):2927-2938. PubMed ID: 32598477
[TBL] [Abstract][Full Text] [Related]
32. SOX11-negative Mantle Cell Lymphoma: Clinicopathologic and Prognostic Features of 75 Patients.
Xu J; Wang L; Li J; Saksena A; Wang SA; Shen J; Hu Z; Lin P; Tang G; Yin CC; Wang M; Medeiros LJ; Li S
Am J Surg Pathol; 2019 May; 43(5):710-716. PubMed ID: 30768440
[TBL] [Abstract][Full Text] [Related]
33. Cancer worry and empathy moderate the effect of a survivorship-focused intervention on quality of life.
Parker PA; Banerjee SC; Matasar MJ; Bylund CL; Schofield E; Li Y; Jacobsen PB; Astrow AB; Leventhal H; Horwitz S; Kissane D
Psychooncology; 2020 Jun; 29(6):1012-1018. PubMed ID: 32128909
[TBL] [Abstract][Full Text] [Related]
34. Molecular profiling and management of mantle cell lymphoma.
Ruan J
Hematology Am Soc Hematol Educ Program; 2019 Dec; 2019(1):30-40. PubMed ID: 31808882
[TBL] [Abstract][Full Text] [Related]
35. SOX11 hypermethylation as a tumor biomarker in endometrial cancer.
Shan T; Uyar DS; Wang LS; Mutch DG; Huang TH; Rader JS; Sheng X; Huang YW
Biochimie; 2019 Jul; 162():8-14. PubMed ID: 30935961
[TBL] [Abstract][Full Text] [Related]
36. Molecular Pathogenesis of Mantle Cell Lymphoma.
Navarro A; Beà S; Jares P; Campo E
Hematol Oncol Clin North Am; 2020 Oct; 34(5):795-807. PubMed ID: 32861278
[TBL] [Abstract][Full Text] [Related]
37. SOX11 Inhibitors Are Cytotoxic in Mantle Cell Lymphoma.
Jatiani SS; Christie S; Leshchenko VV; Jain R; Kapoor A; Bisignano P; Lee C; Kaniskan HÜ; Edwards D; Meng F; Laganà A; Youssef Y; Wiestner A; Alinari L; Jin J; Filizola M; Aggarwal AK; Parekh S
Clin Cancer Res; 2021 Aug; 27(16):4652-4663. PubMed ID: 34158358
[TBL] [Abstract][Full Text] [Related]
38. Targeting DNMT3A-mediated oxidative phosphorylation to overcome ibrutinib resistance in mantle cell lymphoma.
Hoang NM; Liu Y; Bates PD; Heaton AR; Lopez AF; Liu P; Zhu F; Chen R; Kondapelli A; Zhang X; Selberg PE; Ngo VN; Skala MC; Capitini CM; Rui L
Cell Rep Med; 2024 Apr; 5(4):101484. PubMed ID: 38554704
[TBL] [Abstract][Full Text] [Related]
39. EGR1-mediated metabolic reprogramming to oxidative phosphorylation contributes to ibrutinib resistance in B-cell lymphoma.
Liu Y; Kimpara S; Hoang NM; Daenthanasanmak A; Li Y; Lu L; Ngo VN; Bates PD; Song L; Gao X; Bebel S; Chen M; Chen R; Zhang X; Selberg PE; Kenkre VP; Waldmann TA; Capitini CM; Rui L
Blood; 2023 Nov; 142(22):1879-1894. PubMed ID: 37738652
[TBL] [Abstract][Full Text] [Related]
40. Tryptophan metabolite norharman secreted by cultivated Lactobacillus attenuates acute pancreatitis as an antagonist of histone deacetylases.
Zhou Q; Tao X; Guo F; Wu Y; Deng D; Lv L; Dong D; Shang D; Xiang H
BMC Med; 2023 Aug; 21(1):329. PubMed ID: 37635214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]